Efficacy and safety of extended release niacin in combination with atorvastatin in dyslipidemic coronary artery disease patients.(1)Clinico-epidemiological profile and intermediate term follow-up of patients with angiographically normal or mild coronary artery disease and structurally normal heart.(2)